Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan Sells 38,954 Shares

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 38,954 shares of Electromed stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $29.28, for a total transaction of $1,140,573.12. Following the sale, the director now owns 32,622 shares in the company, valued at $955,172.16. This represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Kathleen Skarvan also recently made the following trade(s):

• On Friday, February 14th, Kathleen Skarvan sold 8,640 shares of Electromed stock. The stock was sold at an average price of $32.25, for a total value of $278,640.00.

Electromed Trading Down 0.6 %

ELMD stock opened at $29.36 on Thursday. The company has a market capitalization of $251.32 million, a P/E ratio of 39.15 and a beta of 0.33. The business has a 50 day simple moving average of $31.40 and a 200-day simple moving average of $25.15. Electromed, Inc. has a twelve month low of $13.74 and a twelve month high of $35.56.

Analyst Ratings Changes

Separately, StockNews.com downgraded Electromed from a “strong-buy” rating to a “buy” rating in a report on Wednesday.

Institutional Trading of Electromed

Large investors have recently bought and sold shares of the business. Squarepoint Ops LLC raised its holdings in shares of Electromed by 7.8% in the fourth quarter. Squarepoint Ops LLC now owns 11,366 shares of the company’s stock valued at $336,000 after buying an additional 823 shares during the last quarter. Two Sigma Advisers LP acquired a new position in Electromed in the 4th quarter valued at about $219,000. Two Sigma Investments LP purchased a new stake in Electromed during the 4th quarter valued at approximately $1,255,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Electromed during the 4th quarter worth approximately $119,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in shares of Electromed in the 4th quarter valued at approximately $736,000. Institutional investors and hedge funds own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.